Stability of passivated 316L stainless steel oxide films for cardiovascular stents

Chun Che Shih, Chun Ming Shih, Kuang Yi Chou, Shing Jong Lin, Yea Yang Su

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Passivated 316L stainless steel is used extensively in cardiovascular stents. The degree of chloride ion attack might increase as the oxide film on the implant degrades from exposure to physiological fluid. Stability of 316L stainless steel stent is a function of the concentration of hydrated and hydrolyated oxide concentration inside the passivated film. A high concentration of hydrated and hydrolyated oxide inside the passivated oxide film is required to maintain the integrity of the passivated oxide film, reduce the chance of chloride ion attack, and prevent any possible leaching of positively charged ions into the surrounding tissue that accelerate the inflammatory process. Leaching of metallic ions from corroded implant surface into surrounding tissue was confirmed by the X-ray mapping technique. The degree of thrombi weight percentage [Wao: (2.1 ± 0.9)%; Wep: (12.5± 4.9)%, p <0.01] between the amorphous oxide (AO) and the electropolishing (EP) treatment groups was statistically significant in ex-vivo extracorporeal thrombosis experiment of mongrel dog. The thickness of neointima (T ao: 100± 20 μm Tep: 500± 150 μm, p <0.01) and the area ratio of intimal response at 4 weeks (ARao: 0.62 ± 0.22; ARep: 1.15 ± 0.42, p <0.001) on the implanted iliac stents of New Zealand rabbit could be a function of the oxide properties.

Original languageEnglish
Pages (from-to)861-873
Number of pages13
JournalJournal of Biomedical Materials Research - Part A
Volume80
Issue number4
DOIs
Publication statusPublished - Mar 15 2007

Fingerprint

Stents
Stainless Steel
Oxides
Oxide films
Stainless steel
Ions
Leaching
Chlorides
Tissue
Electrolytic polishing
X rays
Fluids
Experiments

Keywords

  • 316L stainless steel stent
  • Hydrated and hydrolyated oxides
  • Inflammation
  • Neointima
  • Passivated
  • Thrombosis

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials

Cite this

Stability of passivated 316L stainless steel oxide films for cardiovascular stents. / Shih, Chun Che; Shih, Chun Ming; Chou, Kuang Yi; Lin, Shing Jong; Su, Yea Yang.

In: Journal of Biomedical Materials Research - Part A, Vol. 80, No. 4, 15.03.2007, p. 861-873.

Research output: Contribution to journalArticle

Shih, Chun Che ; Shih, Chun Ming ; Chou, Kuang Yi ; Lin, Shing Jong ; Su, Yea Yang. / Stability of passivated 316L stainless steel oxide films for cardiovascular stents. In: Journal of Biomedical Materials Research - Part A. 2007 ; Vol. 80, No. 4. pp. 861-873.
@article{60d465a1b9db4ff48cec62b1ed0ff683,
title = "Stability of passivated 316L stainless steel oxide films for cardiovascular stents",
abstract = "Passivated 316L stainless steel is used extensively in cardiovascular stents. The degree of chloride ion attack might increase as the oxide film on the implant degrades from exposure to physiological fluid. Stability of 316L stainless steel stent is a function of the concentration of hydrated and hydrolyated oxide concentration inside the passivated film. A high concentration of hydrated and hydrolyated oxide inside the passivated oxide film is required to maintain the integrity of the passivated oxide film, reduce the chance of chloride ion attack, and prevent any possible leaching of positively charged ions into the surrounding tissue that accelerate the inflammatory process. Leaching of metallic ions from corroded implant surface into surrounding tissue was confirmed by the X-ray mapping technique. The degree of thrombi weight percentage [Wao: (2.1 ± 0.9){\%}; Wep: (12.5± 4.9){\%}, p <0.01] between the amorphous oxide (AO) and the electropolishing (EP) treatment groups was statistically significant in ex-vivo extracorporeal thrombosis experiment of mongrel dog. The thickness of neointima (T ao: 100± 20 μm Tep: 500± 150 μm, p <0.01) and the area ratio of intimal response at 4 weeks (ARao: 0.62 ± 0.22; ARep: 1.15 ± 0.42, p <0.001) on the implanted iliac stents of New Zealand rabbit could be a function of the oxide properties.",
keywords = "316L stainless steel stent, Hydrated and hydrolyated oxides, Inflammation, Neointima, Passivated, Thrombosis",
author = "Shih, {Chun Che} and Shih, {Chun Ming} and Chou, {Kuang Yi} and Lin, {Shing Jong} and Su, {Yea Yang}",
year = "2007",
month = "3",
day = "15",
doi = "10.1002/jbm.a.30915",
language = "English",
volume = "80",
pages = "861--873",
journal = "Journal of Biomedical Materials Research - Part B Applied Biomaterials",
issn = "1552-4973",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Stability of passivated 316L stainless steel oxide films for cardiovascular stents

AU - Shih, Chun Che

AU - Shih, Chun Ming

AU - Chou, Kuang Yi

AU - Lin, Shing Jong

AU - Su, Yea Yang

PY - 2007/3/15

Y1 - 2007/3/15

N2 - Passivated 316L stainless steel is used extensively in cardiovascular stents. The degree of chloride ion attack might increase as the oxide film on the implant degrades from exposure to physiological fluid. Stability of 316L stainless steel stent is a function of the concentration of hydrated and hydrolyated oxide concentration inside the passivated film. A high concentration of hydrated and hydrolyated oxide inside the passivated oxide film is required to maintain the integrity of the passivated oxide film, reduce the chance of chloride ion attack, and prevent any possible leaching of positively charged ions into the surrounding tissue that accelerate the inflammatory process. Leaching of metallic ions from corroded implant surface into surrounding tissue was confirmed by the X-ray mapping technique. The degree of thrombi weight percentage [Wao: (2.1 ± 0.9)%; Wep: (12.5± 4.9)%, p <0.01] between the amorphous oxide (AO) and the electropolishing (EP) treatment groups was statistically significant in ex-vivo extracorporeal thrombosis experiment of mongrel dog. The thickness of neointima (T ao: 100± 20 μm Tep: 500± 150 μm, p <0.01) and the area ratio of intimal response at 4 weeks (ARao: 0.62 ± 0.22; ARep: 1.15 ± 0.42, p <0.001) on the implanted iliac stents of New Zealand rabbit could be a function of the oxide properties.

AB - Passivated 316L stainless steel is used extensively in cardiovascular stents. The degree of chloride ion attack might increase as the oxide film on the implant degrades from exposure to physiological fluid. Stability of 316L stainless steel stent is a function of the concentration of hydrated and hydrolyated oxide concentration inside the passivated film. A high concentration of hydrated and hydrolyated oxide inside the passivated oxide film is required to maintain the integrity of the passivated oxide film, reduce the chance of chloride ion attack, and prevent any possible leaching of positively charged ions into the surrounding tissue that accelerate the inflammatory process. Leaching of metallic ions from corroded implant surface into surrounding tissue was confirmed by the X-ray mapping technique. The degree of thrombi weight percentage [Wao: (2.1 ± 0.9)%; Wep: (12.5± 4.9)%, p <0.01] between the amorphous oxide (AO) and the electropolishing (EP) treatment groups was statistically significant in ex-vivo extracorporeal thrombosis experiment of mongrel dog. The thickness of neointima (T ao: 100± 20 μm Tep: 500± 150 μm, p <0.01) and the area ratio of intimal response at 4 weeks (ARao: 0.62 ± 0.22; ARep: 1.15 ± 0.42, p <0.001) on the implanted iliac stents of New Zealand rabbit could be a function of the oxide properties.

KW - 316L stainless steel stent

KW - Hydrated and hydrolyated oxides

KW - Inflammation

KW - Neointima

KW - Passivated

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=33847197914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847197914&partnerID=8YFLogxK

U2 - 10.1002/jbm.a.30915

DO - 10.1002/jbm.a.30915

M3 - Article

VL - 80

SP - 861

EP - 873

JO - Journal of Biomedical Materials Research - Part B Applied Biomaterials

JF - Journal of Biomedical Materials Research - Part B Applied Biomaterials

SN - 1552-4973

IS - 4

ER -